Redeye: Doro - It’s not time to give up

This is an update following Doro's Q1 report. Doro continues to gain market share in a tough, declining market. Services now accounts for 18 % of total sales but is likely around 50 % of the earnings. We also expect M&A within Care. All in all, we believe that it is not yet time to give up.

Read more and download the research update: http://bit.ly/2VNLdxq

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/